WRIGHT MEDICAL'S $58 MIL. ACQUISITION OF ORTHOMET
This article was originally published in The Gray Sheet
WRIGHT MEDICAL'S $58 MIL. ACQUISITION OF ORTHOMET would give the Arlington, Tennessee-based orthopedic implant company an immediate presence in the total shoulder implant market, the company says. The two firms announced Sept. 16 a letter-of-intent agreement for Wright to purchase Orthomet's approximately 4.9 mil. outstanding shares of common stock plus all outstanding options for $11 per share. Wright expects that the deal will close in October.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.